Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era-Reference-Cited by-同舟云学术

Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era

Published:2023-08-11 Issue:6 Volume:6 Page:337-340
ISSN:2577-171X
Container-title:IJU Case Reports
language:en
Short-container-title:IJU Case Reports

Author:

Mookerji Nikhile¹^ORCID,Mittal Rohan²,Hui Amaris³,Pfanner Tyler³,Broomfield Stacey¹,Dean Luke¹,Adam Benjamin²,Fung Christopher³,Tamm Alexander³,Kinnaird Adam¹⁴⁵⁶⁷

Affiliation:

1. Division of Urology, Department of Surgery University of Alberta Edmonton Alberta Canada

2. Department of Pathology University of Alberta Edmonton Alberta Canada

3. Department of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta Canada

4. Alberta Prostate Cancer Research Initiative (APCaRI) Edmonton Alberta Canada

5. Cancer Research Institute of Northern Alberta (CRINA) Edmonton Alberta Canada

6. Alberta Centre for Urologic Research and Excellence (ACURE) Edmonton Alberta Canada

7. Department of Oncology University of Alberta Edmonton Alberta Canada

Abstract

IntroductionThe absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding.Case presentationCase of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both magnetic resonance imaging and 18F‐PSMA‐1007 Positron Emission Tomography prior to radical prostatectomy.ConclusionpT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iju5.12614

Reference5 articles.

1. No Residual Cancer on Radical Prostatectomy After Positive 10-Core Biopsy: Incidence, Biopsy Findings, and DNA Specimen Identity Analysis

2. Nondetectable Prostate Carcinoma (pT0) after Radical Prostatectomy: A Narrative Review

3. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer

4. Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: A Cancer Care Ontario updated clinical practice guideline

5. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer;JAMA Oncology;2024-08-01